Optum Rx is nixing reauthorization requirements for more than 60 additional medications. | The PBM giant's list of drugs ...

UnitedHealth stock outlook is in sharp focus as shares stay locked between $300 and $310. With Q2 earnings approaching and ...

Optum Rx officials said they now have eliminated reauthorization requirements for more than 140 chronic disease medications.

UnitedHealth Group shows resilience despite policy and regulatory challenges. Discover why its diversified model and Optum ...

Patrick Conway, who recently became chief executive of the larger Optum health services division, will replace Dr. Amar Desai as CEO of Optum Health.

UnitedHealth Group (UNH) stock gains marginally as the company names a new CEO for its health services division, Optum Health ...

The leader of UnitedHealth Group Inc.’s Optum Health care delivery unit has left the role, an early indication of management ...

Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” ...

UnitedHealth Group’s Optum Rx will remove reauthorization requirements for more than 60 chronic disease medications on July 1.  The cuts are in addition to about 80 reauthorizations Optum Rx ...

UnitedHealth Group's health services segment, Optum Health, will be led by Patrick Conway, according to an internal company ...

The agency overseeing Medicare and Medicaid proposes $4.5 billion of spending cuts for home healthcare, and new economies on ...

Optum CEO Patrick Conway, M.D., will be playing double duty as UnitedHealth Group has named him chief executive of its Optum Health unit, a spokesperson confirmed. | Optum CEO Patrick Conway will be ...